Announcements Trials
Browse Landscape

Phase

Phase 2 9Phase NA 4Phase 3 2Phase 1/2 1

Status

Completed 2Withdrawn 1Unknown 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Carcinoma, Hepatocellular 2Liver Neoplasms 1

Interventions

Cyclophosphamide 299Cisplatin 298Paclitaxel 257Radiotherapy 255Fluorouracil 234Carboplatin 234Docetaxel 230Doxorubicin 216Dexamethasone 166Gemcitabine 156Vincristine 147Etoposide 136Leucovorin 133Capecitabine 129Bevacizumab 129Prednisone 125Rituximab 118Methotrexate 118Cytarabine 110Filgrastim 99Trastuzumab 97Oxaliplatin 96pembrolizumab 83Pemetrexed 73Epirubicin 70Tamoxifen 69Drug Therapy 69Irinotecan 65Granulocyte Colony-Stimulating Factor 60Daunorubicin 58

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Completed × Embolization, Therapeutic × Clear all
NCT02973685 2023-06-12

HAIC Versus TACE for Large Hepatocellular Carcinoma Staged BCLC A/B.

Sun Yat-sen University

Phase 3 Completed
315 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT01229839 2019-03-06

Chemoembolization With or Without Mixing the Chemotherapy With Lipiodol for Unresectable HCC

Sun Yat-sen University

Phase 3 Completed
668 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡